Research
OUR COMMITMENT TO RESEARCH
The School of Pharmacy is one of the UK's leading centres for research in Pharmacy and Pharmaceutical Sciences.
Overview
Our research, led by Director of Research Professor Ryan Donnelly, focuses on making real-world improvements for patients through our expertise in pharmaceutical science and practice.
Research Themes
AREAS OF ACTIVITY
The School of Pharmacy is one of the UK's leading centres for research in Pharmacy and Pharmaceutical Sciences. We have five main research themes.
Research Impact
MAKING A DIFFERENCE TO SOCIETY
Our research focuses on making real-world improvements for patients through our expertise in pharmaceutical science and practice.
GLOBAL COLLABORATIONS
KEY PROJECTS
Our researchers contribute to global and interdisciplinary projects including iABC (Inhaled antibiotics in bronchiectasis and cystic fibrosis) and BREATH, a cross-border project.
POSTGRADUATE RESEARCH OPPORTUNITIES
START YOUR CAREER IN RESEARCH
Interested in PhD study in the school of Pharmacy? Browse our PhD opportunities using the link below
EQUALITY AND DIVERSITY
ATHENA SWAN GOLD AWARD
The School of Pharmacy at Queen’s University Belfast is committed to the Athena SWAN Charter and underpinning beliefs. In 2025, the School received a gold Athena SWAN Award. Currently, we are the only School of Pharmacy in the UK and Ireland to hold the award.
Latest Publications
Redox-active microneedles for disease management
- Brian Youden
- Andrew Carrier
- Naizhen Yu
- Claudia Hodson
- Kehinde Oni
- Fathimath Chirathodi
- Dongchang Yang
- Mark Servos
- Ken Oakes
- Yongli Chen
- Runqing Jiang
- Ryan Donnelly
- Xu Zhang
The influence of drug loading on dissolution behaviours and stability of surfactant-containing amorphous solid dispersions
10 April 2026Cuproptosis in cancer: emerging mechanism and therapeutic opportunities
- Wenyan Qin
- Huan Sheng
- Xiaoyun Hu
- Roberta Burden
- Lorraine Martin
- Huizhe Wu
Emerging ophthalmic drug delivery
- Thakur Raghu Raj Singh
- Lalitkumar Vora
- Rocío Herrero-Vanrell
A five-biomarker IHC-based signature predicting outcome in breast cancer patients following adjuvant anthracycline-based chemotherapy
April 2026
Contact our Researchers
Get in touch
Discover the School
Explore Pharmacy